Hematology

The CGTLive™ Hematology specialty topic page houses the most up-to-date clinical news coverage in the field of hematology gene and cell therapy. It also includes video interviews with key opinion leaders in the field of hematology/oncology about the latest relevant FDA actions, clinical guideline updates, and clinical trial findings related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for various blood disorders.

Latest News

Cokey Nguyen, PhD, the president and chief executive officer of Atara
All of Atara Biotherapeutics’ T-Cell Immunotherapy Trials Placed on Clinical Hold by the FDA

January 21st 2025

The holds are related to a GMP compliance issue at a third-party manufacturing facility.

CGTLive®’s Weekly Rewind
CGTLive®’s Weekly Rewind – January 17, 2025

January 17th 2025

Five Advanced Therapeutics to Watch in 2025
Five Advanced Therapeutics to Watch in 2025

January 16th 2025

FDA Issues CRL for Atara Biotherapeutics’ BLA for T-Cell Immunotherapy Tabelecleucel for EBV+ PTLD
FDA Issues CRL for Atara Biotherapeutics’ BLA for T-Cell Immunotherapy Tabelecleucel for EBV+ PTLD

January 16th 2025

Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado
Transplant Eligibility Versus CAR-T Eligibility

January 16th 2025

Latest CME Events & Activities

Medical Crossfire®: Bridging Evidence to Practice in AML…Updates on FLT3, IDH1/2, Maintenance, Combos, and Clinical Trials

View More

Pediatric-Inspired Asparaginase Regimens for Patients With Acute Lymphocytic Leukemia

View More

Medical Crossfire®: Real World Strategies to Improve Therapeutic Durability and Outcomes in CLL

February 20, 2025

Register Now!

29th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

February 27 - March 2, 2025

Register Now!

The Impact of CAR T-Cell Therapy on Hematological Malignancies

View More

Medical Crossfire®: The Experts Bridge Recent Data in Chronic Lymphocytic Leukemia With Real-World Sequencing Questions

View More

Oncology Briefings™: How Do the Experts Approach Newly Diagnosed Multiple Myeloma?

View More

Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®

View More

ACCC 50th Annual Meeting Pre-Session: Clinical Updates from San Diego on Hematologic Malignancies

View More

Integrating the Latest Algorithms for Prophylaxis and Treatment of Acute and Chronic GvHD: How the Experts Think and Treat

View More

Community Practice Connections™: Pre-Conference Workshop on Immune Cell-Based Therapy

View More

28th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma

View More

New Combination-Based Approaches to Newly Diagnosed MM: What Do the Data, the Experts, and Patients Say?

View More

Medical Crossfire®: Onco-Nurses Exchange Best Practices on PNH Treatment and Symptom Management Along the Patient Care Journey

View More

Show Me Your Care Plan™: How Can Onco-Nurses Improve Patient Care in CML Across the Treatment Continuum?

View More

Show Me Your Care Plan! Managing Breast Cancer Patients Under Current Data for Immuno- and Targeted Therapies, CDK4/6i, ADCs and Beyond

View More

New Combination-Based Approaches to NDMM: What Do the Data, the Experts, and Patients Say?

View More

Broadening Horizons in Newly Diagnosed Multiple Myeloma—Exploring New Combination Approaches and Their Impact

View More

Medical Crossfire®: Risk-Adapted Management of Multiple Myeloma—How Do the Experts Do It?

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

9th Annual Live Medical Crossfire®: Hematologic Malignancies

July 26, 2025

Register Now!

Exploring the Dynamic Shifts in the MDS Treatment Paradigm: Unveiling Advances in Disease Modifying Therapies, Spotlight on Cutting-Edge Clinical Trials, and the Latest Approvals

View More

Community Practice Connections™: Selecting and Sequencing Therapy for Patients with DLBCL in an Era of Expanding Options

View More

New Horizons in Multiple Myeloma Treatment – Selection and Sequencing From Newly Diagnosed to Relapsed/Refractory Disease

View More

Medical Crossfire®: Uncovering The Clinical Utility of Combination Therapies and MRD Assessment in Newly Diagnosed Multiple Myeloma

View More

BURST Expert Illustrations and Commentaries™: Exploring the Mechanistic Rationale for CSF-1R– Directed Treatment in Chronic GVHD

View More

Community Practice Connections™: 8th Annual School of Nursing Oncology™

View More

SimulatEd™: Patient-Centered Care to Improve Outcomes in Chronic Lymphocytic Leukemia

View More

(CME) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

View More

(COPE) Optimizing Management of Ocular Toxicity in Cancer Patients: The Role of Ophthalmologists in the Spectrum of Care

View More

© 2025 MJH Life Sciences

All rights reserved.